Effect of vitamin K2 treatment on carboxylation of osteocalcin in early postmenopausal women

Gynecological Endocrinology

Volumn 22, Issue 8, 2006, Pages 455-459

  Yasui, Toshiyuki ^a   Miyatani, Yuka ^a   Tomita, Junko ^a   Yamada, Masayo ^a   Uemura, Hirokazu ^a   Miura, Masakazu ^b   Irahara, Minoru ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b LSI MEDIENCE CORPORATION   (Japan)

Author keywords

Bone health; Early postmenopause; Undercarboxylated osteocalcin; Vitamin K

Indexed keywords

ALFACALCIDOL; ALKALINE PHOSPHATASE BONE ISOENZYME; DEOXYPYRIDINOLINE; MENATETRENONE; OSTEOCALCIN; ALKALINE PHOSPHATASE; AMINO ACID; BONE DENSITY CONSERVATION AGENT; COLECALCIFEROL; FARNOQUINONE;

ADULT; ARTICLE; BONE DENSITY; BONE TURNOVER; CARBOXYLATION; CLINICAL ARTICLE; DRUG EFFICACY; FEMALE; HUMAN; LUMBAR SPINE; OSTEOPENIA; POSTMENOPAUSE; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; TREATMENT OUTCOME; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG COMBINATION; DRUG EFFECT; METABOLIC BONE DISEASE; METABOLISM; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL; URINE;

ALKALINE PHOSPHATASE; AMINO ACIDS; BONE DENSITY; BONE DENSITY CONSERVATION AGENTS; BONE DISEASES, METABOLIC; CHOLECALCIFEROL; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MIDDLE AGED; OSTEOCALCIN; OSTEOPOROSIS, POSTMENOPAUSAL; POSTMENOPAUSE; VITAMIN K 2;

EID: 33749471305     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.1080/09513590600900402     Document Type: Article

References (32)

1. Szulc P, Chapuy MC, Meunier PJ, Delmas PD. Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture in elderly women. J Clin Invest 1993;91:1769-1774.
2. Szulc P, Arlot M, Chapuy MC, Duboeuf F, Meunier PJ, Delmas PD. Serum undercarboxylated osteocalcin correlates with hip bone mineral density in elderly women. J Bone Miner Res 1994;9:1591-1595.
3. Seibel MJ, Robins SP, Bilezikian JP. Serum undercarboxylated osteocalcin and the risk of hip fracture. J Clin Endocrinol Metab 1997;82:717-718.
4. Vergnaud P, Garnero P, Meunier PJ, Breart G, Kamihagi K, Delmas PD. Undercarboxylated osteocalcin measured with a specific immunoassay predicts hip fracture in elderly women: the EPIDOS study. J Clin Endocrinol Metab 1997;82:719-724.
5. Shearer MJ. The roles of vitamins D and K in bone health and osteoporosis prevention. Proc Nutr Soc 1997;56:915-937.
6. 2 (menatetrenone) effectively prevents fractures and sustains lumbar bone mineral density in osteoporosis. J Bone Miner Res 2000;15:515-521.
7. Iwamoto J, Takeda T, Ichimura S. Effect of menatetrenone on bone mineral density and incidence of vertebral fractures in postmenopausal women with osteoporosis: a comparison with the effect of etidronate. J Orthop Sci 2001;6:487-492.
8. Plantalech L, Guillaumont M, Vergnaud P, Leclercq M, Delmas PD. Impairment of γ carboxylation of circulating osteocalcin (bone Gla protein) in elderly women. J Bone Miner Res 1991;6:1211-1216.
9. Takahashi M, Naitou K, Ohishi T, Kushida K, Miura M. Effect of vitamin K and/or D on undercarboxylated and intact osteocalcin in osteoporotic patients with vertebral or hip fractures. Clin Endocrinol (Oxf) 2001;54:219-224.
10. 3 on bone mineral density and coagulofibrinolysis function in postmenopausal women. Maturitas 2002;41:211-221.
11. Orimo H, Sugioka Y, Fukunaga M, Muto Y, Hotokebuchi T, Gorai I, Nakamura T, Kushida K, Tanaka H, Ikai T, et al. Diagnostic criteria of primary osteoporosis. J Bone Miner Metab 1998;16:139-150.
12. Nakatsuka K, Miki T, Nishizawa Y, Tabata T, Inoue T, Morii H, Ogata E. Circulating bone Gla-protein in end-stage renal disease determined by newly developed two-site immunoradiometric assay. In: Contributions in Nephrology. Morii H, editor. Basel: Karger; 1991. pp 147-154.
13. Gomez B, Ardakani S, Ju J, Jenkins D, Cerelli MJ, Daniloff GY, Kung VT. Monoclonal antibody assay for measuring bone-specific alkaline phosphatase activity in serum. Clin Chem 1995;41:1560-1566.
14. Robins SP, Woitge H, Hesley R, Ju J, Seyedin S, Seibel MJ. Direct enzyme-linked immunoassay for urinary deoxypyridinoline as a specific marker for measuring bone resorption. J Bone Miner Res 1994;9:1643-1649.
15. Yasui T, Yamada M, Kinoshita H, Uemura H, Yoneda N, Irahara M, Aono T, Sunahara S, Mito Y, Kurimoto F, et al. Combination of automatic HPLC-RIA method for determination of estrone and estradiol in serum. J Clin Lab Anal 1999;13:266-272.
16. 2 (menatetrenone) on bone metabolism in postmenopausal women. Endocr J 2002;49: 363-370.
17. 2 enhances osteocalcin accumulation in the extracellular matrix of human osteoblasts in vitro. J Bone Miner Res 1997;12:431-438.
18. 2 modulates proliferation and function of osteoblastic cells in vitro. Biochem Biophys Res Commun 1992;187:814-820.
19. 2 synthesis in vitro. J Bone Miner Res 1991;8:535-542.
20. 2 (menatetrenone) on osteoclast-like cell formation in mouse bone marrow cultures. Eur J Pharmacol 1994;263:181-185.
21. 2 inhibits osteoclastic bone resorption by inducing osteoclast apoptosis. Biochem Biophys Res Commun 1996;220:515-519.
22. Orimo H, Fujita T, Onomura T, Inoue T, Kushida K, Shiraki M. Clinical evaluation of Ea-0167 (menatetrenone) in the treatment of osteoporosis. Clin Eval 1992;20:45-100.
23. Shiraishi A, Takeda S, Masaki T, Higuchi Y, Uchiyama Y, Kubodera N, Sato K, Ikeda K, Nakamura T, Matsumoto T, et al. Alfacalcidol inhibits bone resorption and stimulates formation in an ovariectomized rat model of osteoporosis: distinct actions from estrogen. J Bone Miner Res 2000; 15:770-779.
24. 3 treatment decreases bone turnover and modulates calcium-regulating hormones in early postmenopausal women. Bone 1997;20:557-562.
25. 3-induced mineralization in human periosteal osteoblasts. Calcif Tissue Int 1996;59: 466-473.
26. Matsunaga S, Ito H, Sakou T. The effect of vitamin K and D supplementation on ovariectomy-induced bone loss. Calcif Tissue Int 1999;65:285-289.
27. Meunier PJ. Calcium, vitamin D and vitamin K in the prevention of fractures due to osteoporosis. Osteoporos Int 1999;9:S48-S52.
28. 3. J Bone Miner Res 1992;7:S122.
29. 2 decreased in elderly women with hip fracture. J Bone Miner Res 1993;8: 1241-1245.
30. Booth SL, Tucker KL, Chen H, Hannan MT, Gagnon DR, Cupples LA, Wison PWF, Ordovas J, Schaefer EJ, Dawson-Hughes B, et al. Dietary vitamin K intakes are associated with hip fracture but not with bone mineral density in elderly men and women. Am J Clin Nutr 2000;71: 1201-1208.
31. Feskanich D, Weber P, Willett WC, Rockett H, Booth SL, Colditz GA. Vitamin K intake and hip fractures in women: a prospective study. Am J Clin Nutr 1999;69:74-79.
32. 2: possible implications for hip-fracture risk. Nutrition 2001;17:315-321.